The US Food and Drug Administration granted accelerated approval Friday for the Alzheimers disease drug lecanemab, one of the first experimental dementia drugs to appear to slow the progression of co… [read more]
Alzheimer’s drug lecanemab receives accelerated approval amid safety concerns – CNN
You Might Also Like
Mastodon App: The Social Media Alternative to Twitter? | Tech News Briefing Podcast | WSJ – Wall Street Journal
What we know about the off-duty Alaska Airlines pilot accused of trying to shut off a plane’s engines mid-flight – CNN
